Related Experiment Video
Updated: Jul 18, 2025

09:46
Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model
Published on: September 14, 2009
13.9K
Subacute In-Stent Occlusion 2 Weeks after CASPER Rx Stenting: A Case Report
Eitaro Okumura1, Sho Onodera1, Hiroyuki Jimbo1
1Department of Neurosurgery, Tokyo Medical University Hachioji Medical Center, Hachioji, Tokyo, Japan.
Journal of Neuroendovascular Therapy
|August 23, 2023
Summary
A case report details a CASPER Rx stent complication. In-stent occlusion occurred two weeks after carotid artery stenting in a patient with unstable plaque.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Neurology
Background:
- Carotid artery stenosis poses a significant risk for stroke.
- Dual-layer micromesh stents, like the CASPER Rx stent, are designed for treating carotid artery stenosis, including cases with vulnerable plaque.
- The CASPER Rx stent is indicated for carotid artery stenosis, aiming for safety and efficacy.
Observation:
- A 78-year-old male with symptomatic severe cervical internal carotid artery stenosis and unstable plaque underwent CASPER Rx stent placement.
- The procedure and initial recovery were uneventful, with discharge one week post-procedure.
- Two weeks post-procedure, the patient experienced a transient ischemic attack, revealing acute in-stent and distal internal carotid artery occlusion due to thrombus.
Findings:
- The CASPER Rx stent, intended for carotid artery stenosis, was associated with acute in-stent occlusion two weeks post-implantation.
- Thrombus formation within the stent led to occlusion and subsequent transient ischemic attack.
- Mechanical thrombectomy successfully recanalized the occluded artery, but resulted in postoperative cerebral infarction.
Implications:
- This case highlights a potential complication of CASPER Rx stenting, specifically early in-stent occlusion.
- Further investigation into the safety and long-term patency of dual-layer micromesh stents in vulnerable carotid artery plaque is warranted.
- Understanding the risk factors and mechanisms of early stent thrombosis is crucial for optimizing patient selection and management strategies in carotid artery stenting.
Related Concept Videos
Acute Coronary Syndrome I: Introduction
30
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
30
Acute Coronary Syndrome IV: Interprofessional Care
12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
20
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20

